The Role of Advanced Practice Providers in the Care of Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Gajos, Andrea [1 ]
Tapper, Elliot B. [1 ,2 ]
机构
[1] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Gastroenterol Sect, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
cirrhosis; obesity; liver transplant; patient centered care; RANDOMIZED CONTROLLED-TRIAL; WEIGHT-LOSS; CIRRHOSIS; EPIDEMIOLOGY; EFFICACY; QUALITY; ADULTS;
D O I
10.1016/j.clinthera.2020.12.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States. NAFLD presents unique challenges to conventional health care delivery. Patients require accurate, efficient risk stratification to both individualize clinical management plans and optimize subspecialty resource allocation The hepatology workforce is grossly outmatched by the demand for NAFLD referrals, however. Advanced practice providers (APPs) may be best suited to meeting the challenges of NAFLD care. This article reviews the nature and scope of APP practice, the specific needs posed by NAFLD, and the evidence supporting the comparative advantages of APPs in optimizing the outcomes of patients with NAFLD. Our goal is to show how APPs are uniquely suited to addressing the needs of patients with NAFLD who are seen in hepatology practice, with an emphasis on training philosophy and behavioral intervention. (C) 2020 Elsevier Inc.
引用
收藏
页码:518 / 523
页数:6
相关论文
共 50 条
  • [41] What will happen in patients with advanced nonalcoholic fatty liver disease?
    Kimura, Takefumi
    Tanaka, Naoki
    Tanaka, Eiji
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (03) : 283 - 285
  • [42] The Prevalence of Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease Seen in Primary Care Setting
    Singh, Amandeep
    Jain, Prantesh
    Singh, Ranjeet
    Lopez, Rocio
    Alkhouri, Naim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S354 - S354
  • [43] The role of fatty acids in the development and progression of nonalcoholic fatty liver disease
    Gentile, Christopher L.
    Pagliassotti, Michael J.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2008, 19 (09): : 567 - 576
  • [44] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    PANCREAS, 2010, 39 (08) : 1185 - 1190
  • [45] Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
    Yoneda, Masato
    Kobayashi, Takashi
    Iwaki, Michihiro
    Nogami, Asako
    Saito, Satoru
    Nakajima, Atsushi
    GUT AND LIVER, 2023, 17 (06) : 843 - 852
  • [46] Nonalcoholic Fatty Liver Disease and the Ongoing Role of Liver Biopsy Evaluation
    Brunt, Elizabeth M.
    HEPATOLOGY COMMUNICATIONS, 2017, 1 (05) : 370 - 378
  • [47] The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis
    Papatheodoridi, Alkistis-Maria
    Chrysavgis, Lampros
    Koutsilieris, Michael
    Chatzigeorgiou, Antonios
    HEPATOLOGY, 2020, 71 (01) : 363 - 374
  • [48] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography
    Tada, Toshifumi
    Nishimura, Takashi
    Yoshida, Masahiro
    Iijima, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2020, 47 (04) : 511 - 520
  • [49] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography
    Toshifumi Tada
    Takashi Nishimura
    Masahiro Yoshida
    Hiroko Iijima
    Journal of Medical Ultrasonics, 2020, 47 : 511 - 520
  • [50] MEASURING THE IMPACT OF MUTIDISCIPLINARY CARE IN NONALCOHOLIC FATTY LIVER DISEASE
    Guo, Averill D.
    Kelly, Nicole
    Pomenti, Sydney
    Farrell, Ava
    Staub, Danielle
    Wattacheril, Julia
    GASTROENTEROLOGY, 2020, 158 (06) : S1434 - S1435